Top Pharmaceuticals companies in Belgium by Price to Sales Ratio (P/S)
Belgium
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
177.62 |
Jan. 14, 2025 | USD 2.81 | 6.87% |
|
Belgium |
|
| 2 |
75.67 |
Jan. 14, 2025 | USD 6.22 | -0.06% |
|
Belgium |
|
| 3 |
6.52 |
Jan. 14, 2025 | USD 195.15 | -0.39% |
|
Belgium |
|
| 4 |
6.37 |
Jan. 14, 2025 | USD 24.20 | -0.41% |
|
Belgium |
|
| 5 |
1.51 |
Jan. 14, 2025 | USD 17.21 | 1.09% |
|
Belgium |
|
| 6 |
1.02 |
Jan. 14, 2025 | USD 19.13 | -0.63% |
|
Belgium |
|
| 7 |
0.85 |
Jan. 14, 2025 | USD 13.71 | -0.44% |
|
Belgium |
Frequently Asked Questions
-
Which Pharmaceuticals company in Belgium has the highest Price to Sales Ratio (P/S) ?
The Pharmaceuticals company in Belgium with the highest Price to Sales Ratio (P/S) is Sequana Medical NV (Brussels Stock Exchange: SEQUA.BR) at 177.62.
-
Which Pharmaceuticals company in Belgium has the lowest Price to Sales Ratio (P/S) ?
The Pharmaceuticals company in Belgium with the lowest Price to Sales Ratio (P/S) is Ion Beam Applications SA (Brussels Stock Exchange: IBAB.BR) at 0.85.
-
What are the top 10 Pharmaceuticals companies in Belgium by Price to Sales Ratio (P/S) ?
The top 10 Pharmaceuticals companies in Belgium by Price to Sales Ratio (P/S) are Sequana Medical NV, Hyloris Pharmaceuticals SA, UCB SA, Galapagos NV, Fagron NV, Azelis Group NV and Ion Beam Applications SA.
-
What are the bottom 10 Pharmaceuticals companies in Belgium by Price to Sales Ratio (P/S) ?
The bottom 10 Pharmaceuticals companies in Belgium by Price to Sales Ratio (P/S) are Ion Beam Applications SA, Azelis Group NV, Fagron NV, Galapagos NV, UCB SA, Hyloris Pharmaceuticals SA and Sequana Medical NV.